Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ G6s3\de#U
7Ac.^rv5
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© B?ipo,2~{
L;fz7?_j
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© B5[As
8Sa
$?On,U
1.Co-stimulators (or co-stimulating molecules) 3?TUt{3g
Gn;^]8d
2.NK-kB w I[Hoi
V
WLH ;{
3.Immunoglobulin superfamily k=X)axt1
[K1z/ea)V
4.antigen-presenting cell (APC) m?=J;r"Re
qAt#0
5.death domain D4*_/,}
[@ NW
6.CCR and CXCR <2wC)l3j*
EmyE%$*T
7.Lectin (or mitogen) g
FXz:!A
]2_=(N\Kt
8.Clusters of differentiation, CD) z }V
g4\x&
CDT;AdRw7
9.B7 family i0~Af`v
`2y?(BJp
10.Cytotoxic T lymphocyte, CTL) J2k4k
+y\o^w4sT
11.IL-15 and IL-15 receptor (IL-15R) }4?z<. V
(Mw+SM3<
12.MHC restriction z7pw~Tqlz
ED>P>Gg
13.Affinity-chromatography kpMo7n
{D8yqO A}
14.Cyctosprin A, CsA FJFO0Hb6
/Eu|Jg=I
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) (~fv;}}v
xRZ/[1f!
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© %8>0;ktU
BW ux!
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 gOMy8w4>
EtQ:x$S_
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ER;\Aes*?
.etG>tH
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ vi` VK&+r
AB<%GzW0(
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© #X0Xc2}{f
Bve',.xH
ÃâÒßѧרҵ£º FM|3'a-z
5ka6=R(r
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ j.c{%UYj
[kMWsiZ
Ïû»¯ÄÚ¿Æ£º 3mL(xpT.8z
Z6&bUZF$bE
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ yE;S6 O
cv. j
ѪҺ²¡Ñ§×¨Òµ£º )|W6Z
%CqG/ol
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿